Streck Introduces Updated ARM-D® Kit for Improved Detection
Streck, a leading company in diagnostic solutions, is thrilled to announce the launch of an enhanced version of the ARM-D® Kit, OXA, designed to detect an expanded variety of allelic variants. This new kit identifies 36 additional allelic variants across three newly recognized antimicrobial resistance (AR) gene families. This significant upgrade comes as a direct response to the evolving needs expressed by public health laboratories and aims to provide better oversight of antimicrobial resistance.
Responding to the Needs of Laboratories
The laboratories, particularly those part of the Antimicrobial Resistance Laboratory Network, have increasingly noted the necessity for detection methods capable of identifying diverse gene families and allelic variants. The upgraded Streck ARM-D Kit specifically addresses these needs by including effective detection mechanisms for variants such as OXA-235, OXA-236, and OXA-237 from the OXA-134 family, as well as related beta-lactamase enzymes like OXA-327-like and OXA-198-like.
Commitment to Public Health
Chris Connelly, Streck's director of the Molecular Business Segment, remarked on this enhancement, stating, "We are committed to meeting our customers' needs in public health laboratories. This expanded kit underscores our drive to create tools that aid in better infectious disease testing strategies globally." With this update, Streck aims to further establish itself as a reliable resource for laboratories dedicated to combating antimicrobial resistance.
Comprehensive Detection Capabilities
Streck's ARM-D kits are renowned for their cost-effective and extensive detection abilities, facilitating the identification of over 2,000 allelic variants spanning 25 AR gene families. Results yield a remarkable 100% concordance with whole genome sequencing (WGS) data, marking these kits as crucial pre-WGS screening tools. This capability not only maximizes efficiency but also reduces the expenses associated with AR surveillance efforts in the U.S. and beyond.
Regulatory Information and Usage
It is essential to note that the Streck ARM-D Kit, OXA is designated for research use only and is not cleared for diagnostic procedures. This distinction ensures that the product is utilized appropriately within laboratory settings, underscoring the importance of responsible usage in research applications.
About Streck, Inc.
Founded in 1971, Streck is dedicated to delivering solutions that empower clinical and research laboratories to yield accurate results. The company strives to advance diagnostics, contributing to the enhancement of patient health and well-being across the globe. Manufacturing takes place in La Vista, ensuring that products reach laboratories worldwide, a testament to Streck’s commitment to quality.
Contact Information for Inquiries
For further information regarding the enhancements and capabilities of the ARM-D® Kit, feel free to reach out to Chris Connelly, Director of the Molecular Business Segment, through the provided contact information.
Frequently Asked Questions
What is the ARM-D® Kit, OXA?
The ARM-D® Kit, OXA is a diagnostic tool developed by Streck to detect various allelic variants related to antimicrobial resistance.
How many allelic variants can the kit detect?
The updated kit can now detect over 2,000 allelic variants across 25 gene families.
Is the ARM-D® Kit for general use?
No, the kit is classified for research use only and is not intended for diagnostic procedures.
What makes this kit different from previous versions?
This version includes detection for 36 new allelic variants in three OXA gene families, expanding its overall utility.
Who can benefit from the ARM-D® Kit?
Laboratories engaged in monitoring antimicrobial resistance, especially those in public health, will find this kit particularly beneficial.
